These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1664925)

  • 41. Effects of dopaminergic transmission interruption on the D2 receptor isoforms in various cerebral tissues.
    Martres MP; Sokoloff P; Giros B; Schwartz JC
    J Neurochem; 1992 Feb; 58(2):673-9. PubMed ID: 1309568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Chronic administration of NMDA antagonists induces D2 receptor synthesis in rat striatum.
    Micheletti G; Lannes B; Haby C; Borrelli E; Kempf E; Warter JM; Zwiller J
    Brain Res Mol Brain Res; 1992 Aug; 14(4):363-8. PubMed ID: 1382178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol.
    Memo M; Pizzi M; Missale C; Carruba MO; Spano PF
    Neuropharmacology; 1987 May; 26(5):477-80. PubMed ID: 2955241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopaminergic regulation of cholecystokinin mRNA content in rat striatum.
    Ding XZ; Mocchetti I
    Brain Res Mol Brain Res; 1992 Jan; 12(1-3):77-83. PubMed ID: 1312208
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1989 Oct; 500(1-2):21-9. PubMed ID: 2532557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EEDQ reduces the striatal neurotensin mRNA response to haloperidol.
    Adams MR; Dobie DJ; Merchant KM; Unis A; Dorsa DM
    Peptides; 1997; 18(4):527-35. PubMed ID: 9210171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The problem of antipsychotic treatment for functional imaging in Huntington's disease: receptor binding, gene expression and locomotor activity after sub-chronic administration and wash-out of haloperidol in the rat.
    Besret L; Page KJ; Dunnett SB
    Brain Res; 2000 Jan; 853(1):125-35. PubMed ID: 10627316
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Irreversible blockade of D2 dopamine receptors by fluphenazine-N-mustard increases D2 dopamine receptor mRNA and proenkephalin mRNA and decreases D1 dopamine receptor mRNA and mu and delta opioid receptors in rat striatum.
    Chen JF; Aloyo VJ; Qin ZH; Weiss B
    Neurochem Int; 1994 Oct; 25(4):355-66. PubMed ID: 7820070
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
    Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M
    Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission.
    Calabresi P; De Murtas M; Mercuri NB; Bernardi G
    Ann Neurol; 1992 Apr; 31(4):366-73. PubMed ID: 1350190
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Continuous treatment with the D2 dopamine receptor agonist quinpirole decreases D2 dopamine receptors, D2 dopamine receptor messenger RNA and proenkephalin messenger RNA, and increases mu opioid receptors in mouse striatum.
    Chen JF; Aloyo VJ; Weiss B
    Neuroscience; 1993 Jun; 54(3):669-80. PubMed ID: 8101360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum.
    Doucet JP; Nakabeppu Y; Bedard PJ; Hope BT; Nestler EJ; Jasmin BJ; Chen JS; Iadarola MJ; St-Jean M; Wigle N; Blanchet P; Grondin R; Robertson GS
    Eur J Neurosci; 1996 Feb; 8(2):365-81. PubMed ID: 8714707
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of pertussis toxin on D2-dopamine receptor in rat striatum: evidence for coupling of Ni regulatory protein with D2-receptor.
    Fujita N; Nakahiro M; Fukuchi I; Saito K; Yoshida H
    Brain Res; 1985 May; 333(2):231-6. PubMed ID: 3158374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term haloperidol elevates dopamine D4 receptors by 2-fold in rats.
    Schoots O; Seeman P; Guan HC; Paterson AD; Van Tol HH
    Eur J Pharmacol; 1995 Mar; 289(1):67-72. PubMed ID: 7781713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rat striatal and mesencephalic neurons contain the long isoform of the D2 dopamine receptor mRNA.
    Le Moine C; Bloch B
    Brain Res Mol Brain Res; 1991 Jul; 10(4):283-9. PubMed ID: 1681404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lack of effect of haloperidol or methamphetamine treatment on the mRNA levels of two dopamine D2 receptor isoforms in rat brain.
    Sora I; Fujiwara Y; Tomita H; Ishizu H; Akiyama K; Otsuki S; Yamamura HI
    Jpn J Psychiatry Neurol; 1992 Dec; 46(4):967-73. PubMed ID: 1304623
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Induction by neuroleptics of certain genes in the central nervous system].
    Rogue P; Vincendon G
    Ann Med Psychol (Paris); 1992; 150(2-3):124-6. PubMed ID: 1343505
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine.
    Nguyen TV; Kosofsky BE; Birnbaum R; Cohen BM; Hyman SE
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4270-4. PubMed ID: 1374894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of D2 dopamine receptor mRNA synthesis in a 6-hydroxydopamine parkinsonian rat model.
    Lisovoski F; Haby C; Borrelli E; Schleef C; Revel MO; Hindelang C; Zwiller J
    Brain Res Bull; 1992 May; 28(5):697-701. PubMed ID: 1535533
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine receptor-mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time.
    Taymans JM; Kia HK; Claes R; Cruz C; Leysen J; Langlois X
    Eur J Neurosci; 2004 Apr; 19(8):2249-60. PubMed ID: 15090051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.